A Comparative, Randomized Double Blind Prospective Study to evaluate the use of Dexmedetomidine as adjuvant to Ropivacaine for Transversus Abdominis Plane (TAP) block in patients undergoing in endoscopic Totally Extraperitoneal (TEP) repair of Hernia

Trial Profile

A Comparative, Randomized Double Blind Prospective Study to evaluate the use of Dexmedetomidine as adjuvant to Ropivacaine for Transversus Abdominis Plane (TAP) block in patients undergoing in endoscopic Totally Extraperitoneal (TEP) repair of Hernia

Recruiting
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Ropivacaine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top